Kathryn E. McCollister, PhD

Articles by Kathryn E. McCollister, PhD

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

ByKathryn E. McCollister, PhD,Jared A. Leff, MS,Xuan Yang, MPH, MHS,Joshua D. Lee, MD,Edward V. Nunes, MD,Patricia Novo, MPA, MPH,John Rotrosen, MD,Bruce R. Schackman, PhD,Sean M. Murphy, PhD

November 14th 2018

The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).

Latest Updated Articles

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification
Published: November 14th 2018 | Updated:

Kathryn E. McCollister, PhD

Articles by Kathryn E. McCollister, PhD

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

Latest Updated Articles

Trending on AJMC

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause